An observational study in Pacemaker, Artificial, Cohort Studies and Arrhythmias Requiring Therapy, sponsored by Medical University of Vienna. Completed. Per ClinicalTrials.gov, last updated 2018-01-02.
Sponsored by Medical University of Vienna · Observational
Previous publications suggest gender difference in outcome parameters after pacemaker implantation. Aim of this study is to investigate gender differences in patients with pacemaker. Implanted devices, indication for implantation and pacemaker follow up data of patients will be included. Survival data including cause of death will be documented. Prevalent comorbidities and relevant laboratory data will be recorded.
Women and men with implanted cardiac Pacemaker and at least one follow up in our Pacemaker Office of the Department of Cardiology at the Medical University Vienna. Patients were enrolled regardless of time and place of pacemaker implantations.
Exclusion Criteria:
Patients with implanted cardiac pacemaker registered in pacemaker database of the Department of Cardiology at the Medical University Vienna were included.
Other: No intervention, retrospective analysis only.
No intervention, retrospective analysis only.
Survival after pacemaker implantation
Null hypothesis: There is no survival difference between women and men after pacemaker Implantation.
Time frame: 10 years
Implantation rates of single- or dual-chamber Pacemaker in women/men.
Null hypothesis: Women and men have equal implantation rates of single- and dual-chamber pacemakers.
Time frame: Data obtained: April 30th, 2015
Survival of women/men after single- or dual-chamber pacemaker implantation.
Null hypothesis: Survival after single- or dual-chamber pacemaker implantation is equal.
Time frame: 10 years
First implantation age in single- or dual-chamber pacemaker
Null hypothesis: There is no difference in first implantation age between sexes and single- or dual-chamber pacemakers.
Time frame: Data obtained: April 30th, 2015
Time to device- or lead-replacement
Null hypothesis: There is no difference between women and men in time to device- or lead-replacement.
Time frame: 10 years
Prevalence of Comorbidities
Null hypothesis: There is no difference in survival and first pacemaker implantation when selected comorbidity was found.
Time frame: Survival analysis: 10 years; data obtained: March 2nd, 2016
Survival and device/lead-replacement in patients with diabetes.
Null hypothesis: There is no difference in survival or device/lead-replacement rates in women/men with diabetes.
Time frame: 10 years
Pacemaker parameters
Null hypothesis: There is no difference between women and men in pacing threshold and lead impedance.
Time frame: Data obtained: April 30th, 2015
Laboratory results
Null hypothesis: There is no difference between women and men in troponin T, N-terminal pro-brain natriuretic Peptide, HbA1c and low-density lipoprotein.
Time frame: Data obtained: March 2nd, 2016
No study locations are listed for this record.
Plan to share: Yes — Sharing of IPD is planned.
This study is completed, as verified in Dec 2017. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Medical University of Vienna